Rebecca Heist
Associate Director for Clinical Research, Mass General Brigham Cancer Institute · Mass General Brigham
Credentials: · · · ·
History
- Present
- 1995–1999
1991–1995
Research
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors
Science Translational Medicine · 2011 · 2,891 citations
Review · The Lancet · 2021 · Last of 5 authors · Corresponding · 2,223 citations
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK
Journal of Clinical Oncology · 2009 · 1,584 citations
45 papers
39 papers
32 papers
28 papers
- JG
27 papers · 2 as a fellow
25 papers
- MM
23 papers
- SD
23 papers
Grants
- 2022–2027
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
National Cancer Institute · P50
Project lead · $470.2K · Dana-Farber Cancer Inst
Clinical trials
- 2016–2021
Principal investigator · Completed · Phase 2
Massachusetts General Hospital
- 2012–2019
Cabozantinib in Advanced Solid Malignancies
Principal investigator · Completed · Phase 2
Massachusetts General Hospital
- 2008
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
- 2008–2015
Principal investigator · Completed · Phase 2
Massachusetts General Hospital